Hongbing Zhao
Publications by Year
Research Areas
Synthesis and biological activity, CAR-T cell therapy research, Immunotherapy and Immune Responses, Quinazolinone synthesis and applications, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity(2008)180 cited
- → Synthesis and Biological Evaluation of 2,4,5-Substituted Pyrimidines as a New Class of Tubulin Polymerization Inhibitors(2011)48 cited
- → Grb7 is over-expressed in cervical cancer and facilitate invasion and inhibit apoptosis in cervical cancer cells(2017)17 cited
- → YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance(2011)13 cited
- → Nivolumab and relatlimab for the treatment of melanoma(2023)11 cited
- → Abstract 3604: Preclinical antitumor study of famitinib, an orally available multi-targeted kinase inhibitor of VEGFR/PDGFR/c-Kit in phase I clinical trials(2011)6 cited
- → A novel and simple hollow-fiber assay for in vivo evaluation of nonpeptidyl thrombopoietin receptor agonists(2012)3 cited
- → Advanced Cell Therapies in the Clinical Management(2026)
- Synthesis and antifungal activity of triazole derivatives(2004)
- → Preparation and anti-tumor applications of universal umbilical cord blood-derived, mesothelin-targeted CAR-T cells(2025)